Matches in Wikidata for { <http://www.wikidata.org/entity/Q71102834> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q71102834 description "article scientifique publié en 1996" @default.
- Q71102834 description "artículu científicu espublizáu en xunu de 1996" @default.
- Q71102834 description "im Juni 1996 veröffentlichter wissenschaftlicher Artikel" @default.
- Q71102834 description "scientific article published on 01 June 1996" @default.
- Q71102834 description "wetenschappelijk artikel" @default.
- Q71102834 description "наукова стаття, опублікована в червні 1996" @default.
- Q71102834 name "Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo. Acute effects of bosentan, an orally active, mixed endothelin ETA and ETB receptor antagonist" @default.
- Q71102834 name "Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo. Acute effects of bosentan, an orally active, mixed endothelin ETA and ETB receptor antagonist" @default.
- Q71102834 type Item @default.
- Q71102834 label "Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo. Acute effects of bosentan, an orally active, mixed endothelin ETA and ETB receptor antagonist" @default.
- Q71102834 label "Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo. Acute effects of bosentan, an orally active, mixed endothelin ETA and ETB receptor antagonist" @default.
- Q71102834 prefLabel "Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo. Acute effects of bosentan, an orally active, mixed endothelin ETA and ETB receptor antagonist" @default.
- Q71102834 prefLabel "Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo. Acute effects of bosentan, an orally active, mixed endothelin ETA and ETB receptor antagonist" @default.
- Q71102834 P1433 Q71102834-8A85A439-D60A-4B08-BFC5-D1C2466F844B @default.
- Q71102834 P1476 Q71102834-449FAA56-8558-43DA-99A1-4C4A283A1301 @default.
- Q71102834 P2093 Q71102834-05FA8769-41CA-461F-A3BE-9E6D253DFDF9 @default.
- Q71102834 P2093 Q71102834-0C530E7D-FA36-485D-AD8E-EDAFA430C668 @default.
- Q71102834 P2093 Q71102834-3D673AFF-CEB6-4956-BA1D-BB986AF71D76 @default.
- Q71102834 P2093 Q71102834-4060BAA5-5058-4F7A-A904-BE3128E0604F @default.
- Q71102834 P2093 Q71102834-688F73DF-04AF-4A2B-AAF8-8E1FA46E650D @default.
- Q71102834 P304 Q71102834-408F7D31-0E42-4B66-A9C2-01B9E7B8CEAD @default.
- Q71102834 P31 Q71102834-BB77EB17-2D23-4BE4-A05F-A5C3AB017D5B @default.
- Q71102834 P356 Q71102834-BFE31C06-BABA-4AB8-A3B6-0AE50F90197B @default.
- Q71102834 P407 Q71102834-C16B4ECB-0B05-4C61-9615-6DA8A8E3F564 @default.
- Q71102834 P433 Q71102834-7AFBAAE9-DBC2-4EAA-8E39-33D562CBC394 @default.
- Q71102834 P478 Q71102834-C257170C-AC2E-4C6B-9568-B5C864687910 @default.
- Q71102834 P577 Q71102834-FBEAD2B3-68C1-4D4D-8C48-1BD37E705F94 @default.
- Q71102834 P698 Q71102834-DF1D2F7A-5425-435D-9926-B83850CF67F7 @default.
- Q71102834 P356 01.CIR.93.11.2068 @default.
- Q71102834 P698 8640984 @default.
- Q71102834 P1433 Q578091 @default.
- Q71102834 P1476 "Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo. Acute effects of bosentan, an orally active, mixed endothelin ETA and ETB receptor antagonist" @default.
- Q71102834 P2093 "J D Firth" @default.
- Q71102834 P2093 "K R Boheler" @default.
- Q71102834 P2093 "P A Poole-Wilson" @default.
- Q71102834 P2093 "P H Sugden" @default.
- Q71102834 P2093 "S Kaddoura" @default.
- Q71102834 P304 "2068-2079" @default.
- Q71102834 P31 Q13442814 @default.
- Q71102834 P356 "10.1161/01.CIR.93.11.2068" @default.
- Q71102834 P407 Q1860 @default.
- Q71102834 P433 "11" @default.
- Q71102834 P478 "93" @default.
- Q71102834 P577 "1996-06-01T00:00:00Z" @default.
- Q71102834 P698 "8640984" @default.